Piedmont Capital Management (Montana)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Piedmont Capital Management (Montana)'s AMGN Position: Q2 2026 in Review
Piedmont Capital Management (Montana) reduced its Amgen (AMGN) stake by 0.33% in Q2 2026, selling an estimated $3.08K and leaving 2,678 shares worth $965K. The position accounts for 0.49% of the portfolio, ranked #30.
Piedmont Capital Management (Montana) first reported a position in AMGN in Q2 2021 and has held it in 21 quarters since. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Piedmont Capital Management (Montana) held 2,678 shares of Amgen worth $965K as of Q2 2026.
- Piedmont Capital Management (Montana) sold 9 Amgen shares in Q2 2026, an estimated $3.08K.
- Amgen made up 0.49% of Piedmont Capital Management (Montana)'s portfolio in Q2 2026, its #30 holding.
- Piedmont Capital Management (Montana) first reported a position in Amgen in Q2 2021 and has held it in 21 quarters since.
- 3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Piedmont Capital Management (Montana)'s 13F filing for Q2 2026, filed 13 Aug 2026.